StevenRYtterbergMD
Rheumatology • Rochester, MNMyositis, Rheumatoid Arthritis & Related, Vasculitis
Associate Professor, Internal Medicine, Mayo Medical School
Dr. Ytterberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St Sw
Rochester, MN 55905Phone+1 507-284-2511
Education & Training
University of MichiganFellowship, Rheumatology, 1980 - 1983
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 1976 - 1980- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1976
Certifications & Licensure
MN State Medical License 1984 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Fellow (FACR) American College of Rheumatology
Clinical Trials
- Longitudinal Study for Eosinophilic Granulomatosis With Polyangiitis Start of enrollment: 2006 Apr 01
- Longitudinal Protocol for Granulomatosis With Polyangiitis (Wegener's) and Microscopic Polyangiitis Start of enrollment: 2006 Apr 01
- Determining Disease Activity Biomarkers in Individuals With Polyarteritis Nodosa Start of enrollment: 2006 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 81 citationsRisk of major adverse cardiovascular events with tofacitinib versus tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history o...Christina Charles-Schoeman, Maya H Buch, Maxime Dougados, Deepak L Bhatt, Jon T Giles
Annals of the Rheumatic Diseases. 2023-01-01 - 479 citationsEfficacy of Remission-Induction Regimens for ANCA-associated VasculitisUlrich Specks, Peter A. Merkel, Philip Seo, Robert Spiera, Carol A. Langford
The New England Journal of Medicine. 2013-07-31 - 1694 citationsRituximab versus Cyclophosphamide for ANCA-Associated VasculitisJohn H. Stone, Peter A. Merkel, Robert Spiera, Philip Seo, Carol A. Langford
The New England Journal of Medicine. 2010-07-15
Authored Content
- Arterial Lesions in Giant Cell Arteritis: A Longitudinal StudyMay 2018
- Arterial Lesions in Giant Cell Arteritis: A Longitudinal StudyMay 2018
- Arterial Lesions in Giant Cell Arteritis: A Longitudinal StudyMay 2018
Press Mentions
Xeljanz Safety Study Final Data Details the Increased Risks of Cancers and Major Adverse Cardiovascular EventsJanuary 31st, 2022- Tofacitinib's Cancer, CV Risks Outlined in Older Patients with Rheumatoid ArthritisJanuary 27th, 2022
- Trial Data Confirm Heightened Risks with JAK InhibitorJanuary 26th, 2022
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
